Genmab A (GMAB) Net Debt Issuances and Repayments (2024 - 2025)
Genmab A (GMAB) reported Net Debt Issuances and Repayments of $72.0 million for Q1 2025, up 184.71% on a YoY basis from $25.3 million in Q1 2024, and up 101.84% quarter-over-quarter from -$3.9 billion in Q3 2024.
Genmab A (GMAB) Net Debt Issuances and Repayments (2024 - 2025) Analysis & Trends
Genmab A has reported Net Debt Issuances and Repayments for 2 years, with the latest figure at $72.0 million in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Debt Issuance (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 723,416.35 Bn | 723,416.32 Bn | - | - |
| 2 | Belite Bio | 57,340.00 Bn | 57,340.00 Bn | - | - |
| 3 | Quantum Biopharma | 19,125.08 Bn | 19,125.08 Bn | - | - |
| 4 | Legend Biotech | 3,262.00 Bn | 3,261.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,789.67 Bn | 1,789.67 Bn | - | - |
| 6 | Evaxion A | 1,480.39 Bn | 1,480.37 Bn | - | - |
| 7 | Psyence Biomedical | 241.78 Bn | 241.78 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 113.54 Bn | 106.29 Bn | 2.59 Bn | - |
| 9 | Abivax | 94.26 Bn | 94.26 Bn | - | - |
| 10 | Genmab A | 48.34 Bn | 46.82 Bn | 831.00 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2025 | 72.00 Mn |
| Mar 31, 2025 | 72.00 Mn |
| Sep 30, 2024 | -3.92 Bn |
| Sep 30, 2024 | -3.92 Bn |
| Mar 31, 2024 | -85.00 Mn |
| Mar 31, 2024 | -85.00 Mn |